Recent insights into the molecular biology of melanoma suggest that certain MPM subtypes—particularly those associated with lentigo maligna or desmoplastic variants—may exhibit a high mutational burden and unique gene expression profiles, including frequent alterations in NF1 and TP53 [4,11,12,13]. Here, TP53 is linked to melanoma.